$345.65 Million in Sales Expected for Quaker Chemical Corp (NYSE:KWR) This Quarter

Wall Street brokerages forecast that Quaker Chemical Corp (NYSE:KWR) will report $345.65 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Quaker Chemical’s earnings. The highest sales estimate is $356.00 million and the lowest is $335.30 million. Quaker Chemical reported sales of $222.02 million in the same quarter last year, which indicates a positive year over year growth rate of 55.7%. The business is scheduled to report its next quarterly earnings report on Thursday, November 7th.

On average, analysts expect that Quaker Chemical will report full-year sales of $1.18 billion for the current year, with estimates ranging from $1.15 billion to $1.21 billion. For the next financial year, analysts anticipate that the firm will report sales of $1.67 billion, with estimates ranging from $1.61 billion to $1.71 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Quaker Chemical.

Get Quaker Chemical alerts:

Quaker Chemical (NYSE:KWR) last released its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $1.56 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.56. Quaker Chemical had a return on equity of 18.35% and a net margin of 6.69%. The company had revenue of $205.87 million for the quarter, compared to analyst estimates of $223.15 million. During the same quarter in the prior year, the firm posted $1.56 EPS. Quaker Chemical’s quarterly revenue was down 7.2% compared to the same quarter last year.

Several research firms recently weighed in on KWR. ValuEngine lowered Quaker Chemical from a “buy” rating to a “hold” rating in a report on Friday, August 16th. Janney Montgomery Scott upgraded Quaker Chemical from a “neutral” rating to a “buy” rating in a research note on Friday, June 7th. Finally, Zacks Investment Research lowered Quaker Chemical from a “hold” rating to a “sell” rating in a research note on Thursday, August 8th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. Quaker Chemical presently has a consensus rating of “Hold” and a consensus target price of $193.00.

In other Quaker Chemical news, CEO Michael F. Barry sold 3,834 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $159.02, for a total value of $609,682.68. Following the sale, the chief executive officer now owns 156,301 shares in the company, valued at $24,854,985.02. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 2.90% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. grew its position in shares of Quaker Chemical by 0.5% during the 2nd quarter. BlackRock Inc. now owns 1,914,617 shares of the specialty chemicals company’s stock worth $388,437,000 after buying an additional 9,512 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Quaker Chemical by 36.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 1,426,977 shares of the specialty chemicals company’s stock worth $289,505,000 after buying an additional 380,431 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Quaker Chemical by 3.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 742,144 shares of the specialty chemicals company’s stock worth $145,750,000 after buying an additional 22,997 shares in the last quarter. Northern Trust Corp grew its position in shares of Quaker Chemical by 0.9% during the 2nd quarter. Northern Trust Corp now owns 185,978 shares of the specialty chemicals company’s stock worth $37,731,000 after buying an additional 1,658 shares in the last quarter. Finally, Copeland Capital Management LLC grew its position in shares of Quaker Chemical by 21.3% during the 2nd quarter. Copeland Capital Management LLC now owns 165,914 shares of the specialty chemicals company’s stock worth $33,660,000 after buying an additional 29,122 shares in the last quarter. Institutional investors and hedge funds own 99.45% of the company’s stock.

NYSE:KWR traded up $0.72 during midday trading on Tuesday, hitting $169.24. 2,380 shares of the company traded hands, compared to its average volume of 97,239. The firm’s fifty day moving average is $165.59 and its 200-day moving average is $192.12. Quaker Chemical has a 12-month low of $149.09 and a 12-month high of $224.30. The firm has a market capitalization of $2.23 billion, a P/E ratio of 28.36, a P/E/G ratio of 2.48 and a beta of 1.55. The company has a current ratio of 2.69, a quick ratio of 2.07 and a debt-to-equity ratio of 0.07.

Quaker Chemical Company Profile

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. The company's products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.